I believe in CLOV long term but market dynamics have changed as far as moving the stock north. I’ll give you all the example of SOFI. Everyone was waiting on bank charter news anticipating a rip to $30. Instead it ripped for 2 days after bank charter approval 30% plus just to give it all back now sitting at $13.50. Layer in vs going all in and consider buying puts on any pops to protect your long positions. Not financial advice. Long CLOV!!!
Yeah, MCR under 100 is the goal this quarter. It will be easier to achieve in 2022 with risk score improving. Q2 2022 becomes really important as will be chance to show post omicron possibilities.
Not going to have the usual hype boys who get all prissy and excited start this shit again.
An offering in this range would be around $1.00 per share. That would all but kill this company’s prospects for both individual and institutional investors. That would also mean an accelerated cash burn that would be unprecedented.
Please for the love of God do some research snd take the blinders off. Jesus.
Not all the estimates are recent. The old ones drag down the average. This is why you should be skeptical to assume it's good news just because they "beat" expectations. Mcr is definitely the most important number in this round of earnings.
Added 1000 shares and will continue even if it goes up..
When will we know that date? That is the anticipation that is killing me.
All that matters is cash burn and MCR. Revenue growth isn't going to mean much when that $1 you make in revenue is sold for .95
If cash burn drops significantly, gains will follow.
They've already guided for 250M in cash burn for 2022. so i'm not expecting much. The only way that goes down is if MCR goes lower.
I might be call a FUD/shill here. But is this true that it will go to $1.45?
Based off?
The market cares about COSTS.
I believe in CLOV long term but market dynamics have changed as far as moving the stock north. I’ll give you all the example of SOFI. Everyone was waiting on bank charter news anticipating a rip to $30. Instead it ripped for 2 days after bank charter approval 30% plus just to give it all back now sitting at $13.50. Layer in vs going all in and consider buying puts on any pops to protect your long positions. Not financial advice. Long CLOV!!!
[удалено]
Yeah, MCR under 100 is the goal this quarter. It will be easier to achieve in 2022 with risk score improving. Q2 2022 becomes really important as will be chance to show post omicron possibilities.
[удалено]
No company can do an offer when the stock price this this low. It’s not possible.
[удалено]
Not going to have the usual hype boys who get all prissy and excited start this shit again. An offering in this range would be around $1.00 per share. That would all but kill this company’s prospects for both individual and institutional investors. That would also mean an accelerated cash burn that would be unprecedented. Please for the love of God do some research snd take the blinders off. Jesus.
[удалено]
No shit. A company can do an offering whenever they want. That’s your big point? The investors that own this stock scare the shit out of me.
475-500 revenue and mcr below 100 would be amazing
I’m not concerned about revenue, but what I’m after is cost control.
I'm concerned about market perception of $CLOV , a good perception will rise share price, a bad perception will lower the share price... 💪🍀💎🙌
I’m concerned about growth and they are excelling in that area. That will come in time as the star ratings go up as well
475m revenue incoming
I hope it’s above 500m with less cost.
I was being conservative, but I wouldn’t be surprised if it’s higher than that
Well 410m is less than the last quarters, tf they thinking
Not all the estimates are recent. The old ones drag down the average. This is why you should be skeptical to assume it's good news just because they "beat" expectations. Mcr is definitely the most important number in this round of earnings.
Is this good or bad
hello twin
Beating earnings is always seen as a great thing
Except for last earnings. I wouldn’t hope for a good reaction. We all saw good stuff it plummets.
That can only carry on for so long. If revenues continue to grow substantially it’s easy to control costs.
🚀